ZhuZhou QianJin Pharmaceutical Co Ltd Strategic Asset Allocation Index
ZhuZhou QianJin Pharmaceutical Co Ltd strategic asset allocation index. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Strategic Asset Allocation Index of 21.7% as of June 2023. Strategic assets (PP&E of CN¥603.36 Million plus long-term investments of CN¥-) total CN¥603.36 Million, measured against net assets of CN¥2.78 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ZhuZhou QianJin Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2021)
Strategic asset allocation index of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2021. This chart shows how ZhuZhou QianJin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 21.7%, representing strategic assets of CN¥603.36 Million against net assets of CN¥2.78 Billion CNY. Check ZhuZhou QianJin Pharmaceutical Co Ltd (600479) tangible equity ratio to evaluate the tangible quality of the company's equity base.
ZhuZhou QianJin Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2001–2021)
ZhuZhou QianJin Pharmaceutical Co Ltd strategic asset allocation index by year from 2001 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ZhuZhou QianJin Pharmaceutical Co Ltd market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 23.3% | CN¥630.19 Million | CN¥630.19 Million | CN¥- | CN¥2.70 Billion | ▲ +5.6 pp |
| 2020 | 17.8% | CN¥490.50 Million | CN¥490.50 Million | CN¥- | CN¥2.76 Billion | ▼ -0.4 pp |
| 2019 | 18.2% | CN¥478.66 Million | CN¥478.66 Million | CN¥- | CN¥2.63 Billion | ▼ -4.2 pp |
| 2018 | 22.4% | CN¥544.70 Million | CN¥499.35 Million | CN¥45.35 Million | CN¥2.43 Billion | ▼ -3.2 pp |
| 2017 | 25.6% | CN¥574.56 Million | CN¥529.21 Million | CN¥45.35 Million | CN¥2.24 Billion | ▼ -3.7 pp |
| 2016 | 29.3% | CN¥610.75 Million | CN¥565.40 Million | CN¥45.35 Million | CN¥2.08 Billion | ▲ +2.5 pp |
| 2015 | 26.8% | CN¥526.74 Million | CN¥491.39 Million | CN¥35.35 Million | CN¥1.96 Billion | ▼ -3.1 pp |
| 2014 | 30.0% | CN¥415.18 Million | CN¥415.18 Million | CN¥- | CN¥1.39 Billion | ▼ -20.3 pp |
| 2013 | 50.3% | CN¥605.69 Million | CN¥605.69 Million | CN¥- | CN¥1.20 Billion | ▲ +0.5 pp |
| 2012 | 49.8% | CN¥529.80 Million | CN¥529.80 Million | CN¥- | CN¥1.06 Billion | ▲ +14.5 pp |
| 2011 | 35.3% | CN¥350.56 Million | CN¥350.56 Million | CN¥- | CN¥993.56 Million | ▲ +0.5 pp |
| 2010 | 34.8% | CN¥327.11 Million | CN¥327.11 Million | CN¥- | CN¥939.81 Million | ▼ -0.1 pp |
| 2009 | 34.9% | CN¥332.32 Million | CN¥332.32 Million | CN¥- | CN¥951.29 Million | ▲ +7.7 pp |
| 2008 | 27.2% | CN¥238.12 Million | CN¥238.12 Million | CN¥- | CN¥875.75 Million | ▲ +8.0 pp |
| 2007 | 19.2% | CN¥171.60 Million | CN¥171.60 Million | CN¥- | CN¥895.95 Million | ▼ -7.1 pp |
| 2006 | 26.3% | CN¥173.26 Million | CN¥173.26 Million | CN¥- | CN¥659.60 Million | ▼ -1.1 pp |
| 2005 | 27.4% | CN¥162.96 Million | CN¥162.96 Million | CN¥- | CN¥594.85 Million | ▲ +2.1 pp |
| 2004 | 25.3% | CN¥163.01 Million | CN¥163.01 Million | CN¥- | CN¥644.15 Million | ▼ -39.1 pp |
| 2003 | 64.4% | CN¥150.21 Million | CN¥150.21 Million | CN¥- | CN¥233.07 Million | ▼ -8.1 pp |
| 2002 | 72.6% | CN¥134.71 Million | CN¥134.71 Million | CN¥- | CN¥185.56 Million | ▲ +21.0 pp |
| 2001 | 51.6% | CN¥77.33 Million | CN¥77.33 Million | CN¥- | CN¥149.94 Million | — |